CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the RBC Capital Markets Healthcare Conference at 8:00 a.m. EST on March 2, 2010, in New York City.
